The response to your query is detailed below:
- Numbers of patients treated with the new oral anti-coagulation treatments:
| Drug | Number patients treated in the last 3 months |
| Rivaroxaban (Xarelto) | 166 |
| Dabigatran (Pradaxa) | 50 |
| Apixaban (Eliquis) | 71 |
- What is the usual dose/strength for the following treatments, for each of the indications listed:
| Drug | Typical does for VTE prophylaxis | Typical dose for ACS | Typical dose for AF |
| Rivaroxaban (Xarelto) | As per NICE/BNF: 10mg BD | Not used | As per NICE/BNF: 20mg OD |
| Dabigatran (Pradaxa) | As per NICE/BNF: 110mg STAT then 220mg OD | Not used | As per NICE/BNF: 150mg BD |
| Apixaban (Eliquis) | As per NICE/BNF: 2.5mg BD | Not used | As per NICE/BNF: 5mg BD |
- If possible, please split the patients by the following diagnosis;
| Drug | Acute cardiac syndrome (ACS)
|
Venous Thrombo-embolism (VTE) | Prophylaxis of VTE |
| Rivaroxaban (Xarelto) | We are not able to split prescription by diagnosis | ||
| Dabigatran (Pradaxa) | |||
| Apixaban (Eliquis) | |||
- Please fill in the following table relating to dispensed items in the last 3 months:
| Drug & strength | Number of items dispensed from pharmacy |
| Rivaroxaban (Xarelto) 20mg | 107.75 boxes of 28 |
| Rivaroxaban (Xarelto) 10mg | 15.9 boxes of 30 |
| Rivaroxaban (Xarelto) 15mg | 141.04 boxes of 28 |
| Dabigatran (Pradaxa) 110mg | 18.07 boxes of 60 |
| Dabigatran (Pradaxa) 75mg | Not Kept |
| Dabigatran (Pradaxa) 150mg | 31.80 boxes of 60 |
| Apixaban (Eliquis) 2.5mg | 45.7 boxes of 60 |
| Apixaban (Eliquis) 5mg | 32.75 boxes of 56 |
